Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells
Crossref DOI link: https://doi.org/10.1007/s13277-015-3997-7
Published Online: 2015-09-02
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Ming
Zhang, Weiyi
Tang, Wei
Wang, Yanjuan
Zhao, Xingzeng
Wang, Xiangyun
Qi, Xin
Li, Jing
Text and Data Mining valid from 2015-09-02